IRCT20200105046010N38招募中未知
In- Vivo Bioequivalence study of Tofacitinib tablet 10 mg Nano Alvand Pharma (RHOFANIB®) with brand drugs (XELJANZ® 10 mg, Pfizer, Ireland) in Iranian healthy volunteers.
anoalvand Pharmaceutical Co0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •General health
- •Body mass index(18-28)
- •Informed consent
- •Age(18-60)
排除标准
- •A history of cardiovascular disease
- •A history of liver & kidney disease
- •Alcohol & Drug addiction
- •Hypersensitivity to the drug
研究者
相似试验
招募中
Unknown
Bioequivalence study of Tofacitinib 10 mg tabletIRCT20200105046010N79Tabriz University of Medical Sciences24
招募中
3 期
Efficacy and safety of tofacitinib on clinical improvement in patients with COVID19COVID-19 pneumonia.Covid-19 diseaseU07.1IRCT20190804044429N7Mazandaran University of Medical Sciences240
尚未招募
4 期
sefulness of tofacitinib in atopic dermatitisCTRI/2024/08/072026AIIMS Bhubaneswar
尚未招募
Unknown
A clinical trial to Study the effects of oral tofacitinib and azathioprine in chronic actinic dermatitisCTRI/2023/03/051181Krishna Vishwa Vidyapeeth
招募中
1 期
Effects of Tofacitinib on Ulcerative Colitis patientslcerative Colitis.Ulcerative colitisIRCT20181217042020N2Digestive Disease Research Institute of Tehran University of Medical Sciences40